Singapore markets open in 8 hours 27 minutes

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.16-0.34 (-5.18%)
As of 11:10AM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 28.75M
Enterprise value 22.88M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)92.02
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.60

Trading information

Stock price history

Beta (5Y monthly) 2.35
52-week change 367.96%
S&P500 52-week change 314.90%
52-week high 313.17
52-week low 32.11
50-day moving average 35.39
200-day moving average 36.80

Share statistics

Avg vol (3-month) 312.86k
Avg vol (10-day) 318.02k
Shares outstanding 54.42M
Implied shares outstanding 64.44M
Float 84.41M
% held by insiders 10.31%
% held by institutions 117.76%
Shares short (14 Nov 2023) 456.67k
Short ratio (14 Nov 2023) 43.5
Short % of float (14 Nov 2023) 41.28%
Short % of shares outstanding (14 Nov 2023) 41.28%
Shares short (prior month 12 Oct 2023) 461.71k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:30
Last split date 313 Feb 2023

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Sept 2023


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-51.96%
Return on equity (ttm)-224.63%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-16.14M
EBITDA -45.09M
Net income avi to common (ttm)-47.46M
Diluted EPS (ttm)-11.12
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)28.73M
Total cash per share (mrq)6.49
Total debt (mrq)22.86M
Total debt/equity (mrq)7,349.08%
Current ratio (mrq)0.99
Book value per share (mrq)0.07

Cash flow statement

Operating cash flow (ttm)-37.55M
Levered free cash flow (ttm)-20.2M